|
|
||||||||
1 Istituto di Genetica Biochimica ed Evoluzionistica del C.N.R., via Abbiategrasso 207, I-27100 Pavia, Italy
2 Rega Institute and University Hospital, Leuven, Belgium
3 IRCCS Policlinico S. Matteo, Pavia, Italy
4 Istituto Patologia Medica, Parma, Italy
and5 Istituto Biologia e Genetica, Università di Verona, Italy
The complete nucleotide sequence of a human T-cell lymphotropic virus type II isolate (HTLV-II-Gu) from an Italian injecting drug user was obtained, representing the first entire sequence of a European HTLV-II isolate. The HTLV-II-Gu genome was more similar to the HTLV-IIb-NRA isolate (98.4%) and HTLV-IIb-G12 (98.2%) than to HTLV-IIa-Mo (95.2%). The classification of HTLV-II-Gu as subtype IIb was confirmed by restriction analysis. Just as for HTLV-IIa strain Mo, HTLV-IIb-Gu cultured lymphocytes produce two additional mRNAs generated through alternative splicing in the pX region. A phylogenetic analysis was performed by using the methods of neighbour-joining and parsimony with bootstrapping, and maximum likelihood. The different gene regions were analysed separately, comparing Gu with all other HTLV-II strains presently available. In the LTR, as well as in other genome regions, a clear separation between IIa and IIb was evident, and within the IIb subtype three clusters were present of which two were well supported; one contained exclusively Amerindian strains and the other included all Italian and Spanish strains together with two strains obtained from New York drug users. All data clearly showed that HTLV-IIa and IIb subtypes are closely related and are equidistant from HTLV-I, suggesting that both groups evolved simultaneously. The results suggest that HTLV-II-Gu and other IIb South European isolates were probably derived from North American IIb isolates. The data also indicate that sequence analysis is necessary to further classify IIa and IIb subtypes.
* Author for correspondence. Current address: Rega Institute, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Fax +32 16332131, e-mail marco.salemi@uz.kuleuven.ac.be
Received 10 October 1995;
accepted 13 February 1996.
This article has been cited by other articles:
![]() |
M. Salemi, M. Lewis, J. F. Egan, W. W. Hall, J. Desmyter, and A.-M. Vandamme Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes PNAS, November 9, 1999; 96(23): 13253 - 13258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Slattery, G. Franchini, and A. Gessain Genomic Evolution, Patterns of Global Dissemination, and Interspecies Transmission of Human and Simian T-cell Leukemia/Lymphotropic Viruses Genome Res., June 1, 1999; 9(6): 525 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Vandamme, M. Salemi, M. Van Brussel, H.-F. Liu, K. Van Laethem, M. Van Ranst, L. Michels, J. Desmyter, and P. Goubau African Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe Pygmies J. Virol., May 1, 1998; 72(5): 4327 - 4340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casoli, M. C. Re, P. Monari, G. Furlini, G. Tosi, C. Gradozzi, P. P. Dall'Aglio, U. Bertazzoni, and R. S. Accolla Human T-Cell Leukemia Virus Type II Directly Acts on CD34+ Hematopoietic Precursors by Increasing Their Survival Potential. Envelope-Associated HLA Class II Molecules Reverse This Effect Blood, April 1, 1998; 91(7): 2296 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Letourneur, L d'Auriol, M. Dazza, M Peteers, I Bedjabaga, P Piot, E Delaporte, A Gessain, and N Monplaisir Complete nucleotide sequence of an African human T-lymphotropic virus type II subtype b isolate (HTLV-II-Gab): molecular and phylogenetic analysis J. Gen. Virol., February 1, 1998; 79(2): 269 - 277. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |